FDA recall, , Moderate risk
American National Red Cross Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced were collected from a donor deferred for accidental blood exposure.
The American National Red Cross began this recall on Jun 2, 2025. FDA posted it on Oct 27, 2026, the day the recall ended.
Summary by Recall Canary from the FDA notice
What happened
The American National Red Cross, located in Maryland Heights, Missouri, voluntarily initiated a recall of Red Blood Cells, Leukocytes Reduced on June 2, 2025. The product was collected from a donor who was deferred for accidental blood exposure and was distributed in Tennessee. The FDA added the recall to its Enforcement Report and classified it on October 27, 2026, with the weekly enforcement report on November 4, 2026. Customers were notified by telephone.
What to do
Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.
What was recalled
Hospitals, clinics and blood banks match these details against their records.
Red Blood Cells, Leukocytes Reduced
- Unit number
- W181125304288009
Recall details
- Posted by FDA
- Recall began
- Status
- Ended Oct 27, 2026
- Weekly archive
- Listed the week of Oct 26, 2026
- Distributed to
- Recalled by
- The American National Red CrossMaryland Heights, Missouri
- Hazard
- Donor screening problem
- Risk
Moderate risk
Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 99793
- Recall number
- B-0029-2027
- Recall type
- Voluntary: Firm initiated
- How the company first told customers
- Telephone
All recalls from The American National Red Cross
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
The American National Red Cross began the recall
FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it
Added to Recall Canary
Summary updated